A detailed history of Custom Index Systems, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Custom Index Systems, LLC holds 1,261 shares of VRTX stock, worth $607,663. This represents 0.3% of its overall portfolio holdings.

Number of Shares
1,261
Previous 1,707 26.13%
Holding current value
$607,663
Previous $695 Million 24.11%
% of portfolio
0.3%
Previous 0.43%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$407.69 - $446.08 $181,829 - $198,951
-446 Reduced 26.13%
1,261 $527 Million
Q4 2023

Jan 26, 2024

BUY
$343.0 - $410.68 $585,501 - $701,030
1,707 New
1,707 $695 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $124B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Custom Index Systems, LLC Portfolio

Follow Custom Index Systems, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Custom Index Systems, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Custom Index Systems, LLC with notifications on news.